Abbvie Inc. (ABBV)
NYSE: ABBV · Pharmaceutical Preparations · North Chicago, IL · filing with the SEC since 2012
Grade6.3
◀ Past 8.0● Present 6.1▶ Future 4.7
Who owns Abbvie Inc.
As filed with the SECHolders of 5% or more
1
Vanguard Capital Management holds 7.51% of Common Stock, as its SCHEDULE 13G filed Apr 29, 2026 says.
Directors and officers
21
report now, of 37 people on the record since 2012. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 10% in Jul 7, 2025
What ABBV reports owning in othersstakes of 5% or more, and other ties
Xilio Therapeutics, Inc. XLO
SCHEDULE 13G · filed Feb 18, 2025 · Common Stock, par value $0.0001 per share
Other ties the annual report names
Nimble Therapeutics, Inc.
A company bought · acquisition · Jan 2025 · owns, named in the 10-K filed Feb 20, 2026
Cerevel Therapeutics
A company bought · acquisition · Jul 2024 · owns, named in the 10-K filed Feb 20, 2026
Immuno Gen
A company bought · acquisition · Jan 2024 · owns, named in the 10-K filed Feb 20, 2026
280 subsidiaries in 64 countries, from the list filed with the 10-K filed Feb 20, 2026.
Insider tradesForm 4
7sales
0purchases
4sales on a scheduled plan
4people selling
$30.8Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 37 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | 1 | $11.9M | 0 | 0 | $0 |
| Siatis Perry C | EVP, GC AND SECRETARY | 4 | $9.5M | 4 | 0 | $0 |
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | 1 | $8.2M | 0 | 0 | $0 |
| Purdue David Ryan | SVP, Controller | 1 | $1.2M | 0 | 0 | $0 |